154 related articles for article (PubMed ID: 24100255)
1. Development of acute pulmonary hypertension after bortezomib treatment in a patient with multiple myeloma: a case report and the review of the literature.
Akosman C; Ordu C; Eroglu E; Oyan B
Am J Ther; 2015; 22(3):e88-92. PubMed ID: 24100255
[TBL] [Abstract][Full Text] [Related]
2. Sequential vincristine, adriamycin, dexamethasone (VAD) followed by bortezomib, thalidomide, dexamethasone (VTD) as induction, followed by high-dose therapy with autologous stem cell transplant and consolidation therapy with bortezomib for newly diagnosed multiple myeloma: results of a phase II trial.
Kim HJ; Yoon SS; Lee DS; Sohn SK; Eom HS; Lee JL; Chung JS; Kim K; Suh C; Won JH; Kim JS; Park JS; Kang HJ; Seong CM; Kim CS; Lee SJ; Lee JH
Ann Hematol; 2012 Feb; 91(2):249-56. PubMed ID: 21789621
[TBL] [Abstract][Full Text] [Related]
3. [Effective combination therapy of bortezomib and dexamethasone for two patients with refractory multiple myeloma].
Ikeda H; Hayashi T; Nojima M; Yasui H; Ikeda Y; Ishida T; Adachi M; Imai K
Rinsho Ketsueki; 2005 Apr; 46(4):269-73. PubMed ID: 16444959
[TBL] [Abstract][Full Text] [Related]
4. Severe heart failure after bortezomib treatment in a patient with multiple myeloma: a case report and review of the literature.
Bockorny M; Chakravarty S; Schulman P; Bockorny B; Bona R
Acta Haematol; 2012; 128(4):244-7. PubMed ID: 22964848
[TBL] [Abstract][Full Text] [Related]
5. [Observational retrospective study to evaluate the effectiveness and safety of treatment schemes with bortezomib for multiple myeloma in our hospital].
Titos-Arcos JC; León-Villar J; de Arriba de la Fuente F; Moreno Belmonte MJ; Iranzo Fernández MD
Farm Hosp; 2012; 36(4):275-81. PubMed ID: 22115856
[TBL] [Abstract][Full Text] [Related]
6. Bortezomib in combination with dexamethasone and subsequent thalidomide for newly-diagnosed multiple myeloma: a Chinese experience.
Zheng W; Wei G; Ye X; He J; Li L; Wu W; Shi J; Zhang J; Huang W; Xie W; Luo Y; Xue X; Lin M; Huang H; Cai Z
Leuk Res; 2009 Dec; 33(12):1615-8. PubMed ID: 19773080
[TBL] [Abstract][Full Text] [Related]
7. Cutaneous adverse reactions linked to targeted anticancer therapies bortezomib and lenalidomide for multiple myeloma: new drugs, old side effects.
Patrizi A; Venturi M; Dika E; Maibach H; Tacchetti P; Brandi G
Cutan Ocul Toxicol; 2014 Mar; 33(1):1-6. PubMed ID: 23638756
[TBL] [Abstract][Full Text] [Related]
8. Bortezomib-induced Sweet's syndrome confirmed by rechallenge.
Zobniw CM; Saad SA; Kostoff D; Barthel BG
Pharmacotherapy; 2014; 34(4):e18-21. PubMed ID: 24338786
[TBL] [Abstract][Full Text] [Related]
9. Mechanisms of peripheral neuropathy associated with bortezomib and vincristine in patients with newly diagnosed multiple myeloma: a prospective analysis of data from the HOVON-65/GMMG-HD4 trial.
Broyl A; Corthals SL; Jongen JL; van der Holt B; Kuiper R; de Knegt Y; van Duin M; el Jarari L; Bertsch U; Lokhorst HM; Durie BG; Goldschmidt H; Sonneveld P
Lancet Oncol; 2010 Nov; 11(11):1057-65. PubMed ID: 20864405
[TBL] [Abstract][Full Text] [Related]
10. Acute pancreatitis caused by bortezomib.
Solakoglu T; Akyol P; Guney T; Dilek I; Atalay R; Koseoglu H; Akin E; Demirezer Bolat A; Buyukasik NS; Ersoy O
Pancreatology; 2013; 13(2):189-90. PubMed ID: 23561979
[TBL] [Abstract][Full Text] [Related]
11. Resolution of bilateral cystoid macular edema and subfoveal serous retinal detachments after treatment with bortezomib in a patient with "smoldering" multiple myeloma.
Grannis CH; Dewan VN; Wang RC
Retin Cases Brief Rep; 2014; 8(4):348-51. PubMed ID: 25372546
[TBL] [Abstract][Full Text] [Related]
12. Bortezomib-induced acute pancreatitis: Case report and review of the literature.
Talamo G; Sivik J; Pandey MK; Mir MA
J Oncol Pharm Pract; 2016 Apr; 22(2):332-4. PubMed ID: 25516544
[TBL] [Abstract][Full Text] [Related]
13. Bortezomib-induced syndrome of inappropriate antidiuresis in a patient with multiple myeloma: A case report and literature review
.
Peng B; Chen H; Lou X
Int J Clin Pharmacol Ther; 2017 Dec; 55(12):910-914. PubMed ID: 29092733
[TBL] [Abstract][Full Text] [Related]
14. Bortezomib-induced acute interstitial nephritis.
Cheungpasitporn W; Leung N; Rajkumar SV; Cornell LD; Sethi S; Angioi A; Fervenza FC
Nephrol Dial Transplant; 2015 Jul; 30(7):1225-9. PubMed ID: 26109684
[TBL] [Abstract][Full Text] [Related]
15. [Treatment with a proteasome inhibitor, bortezomib, for thalidomide-resistant multiple myeloma].
Takatoku M; Noborio-Hatano K; Takahashi S; Kikuchi S; Mori M; Muroi K; Komatsu N; Ozawa K
Rinsho Ketsueki; 2004 Feb; 45(2):144-8. PubMed ID: 15045823
[TBL] [Abstract][Full Text] [Related]
16. Neurotoxicity of bortezomib therapy in multiple myeloma: a single-center experience and review of the literature.
Badros A; Goloubeva O; Dalal JS; Can I; Thompson J; Rapoport AP; Heyman M; Akpek G; Fenton RG
Cancer; 2007 Sep; 110(5):1042-9. PubMed ID: 17654660
[TBL] [Abstract][Full Text] [Related]
17. Bortezomib plus thalidomide for newly diagnosed multiple myeloma in China.
Chen SL; Jiang B; Qiu LG; Yu L; Zhong YP; Gao W
Anat Rec (Hoboken); 2010 Oct; 293(10):1679-84. PubMed ID: 20734318
[TBL] [Abstract][Full Text] [Related]
18. Bortezomib-induced perivascular dermatitis in a patient with multiple myeloma.
Ozkurt ZN; Sucak GT; Aki SZ; Yağci M; Erdem O
Cutan Ocul Toxicol; 2009; 28(3):141-3. PubMed ID: 19548772
[TBL] [Abstract][Full Text] [Related]
19. Bortezomib in the front-line treatment of multiple myeloma.
Richardson PG; Mitsiades C; Schlossman R; Ghobrial I; Hideshima T; Munshi N; Anderson KC
Expert Rev Anticancer Ther; 2008 Jul; 8(7):1053-72. PubMed ID: 18588451
[TBL] [Abstract][Full Text] [Related]
20. Pneumonitis associated with bortezomib in a patient with multiple myeloma.
Kars TU; Yaşkıran O; Çeneli Ö
J Oncol Pharm Pract; 2023 Jun; 29(4):1021-1024. PubMed ID: 36476141
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
